Crossref journal-article
Ovid Technologies (Wolters Kluwer Health)
Current Opinion in Neurology (276)
Bibliography

Hung, A. Y., & Schwarzschild, M. A. (2007). Clinical trials for neuroprotection in Parkinson??s disease: overcoming angst and futility? Current Opinion in Neurology, 20(4), 477–483.

Authors 2
  1. Albert Y Hung (first)
  2. Michael A Schwarzschild (additional)
References 68 Referenced 30
  1. 10.1212/01.wnl.0000206363.57955.1b / Neurology by Suchowersky (2006)
  2. 10.1212/WNL.66.10_suppl_4.S2 / Neurology by Poewe (2006)
  3. 10.1001/jama.281.4.341 / JAMA by Tanner (1999)
  4. 10.1038/nn941 / Nat Neurosci by Dawson (2002)
  5. 10.1602/neurorx.1.1.139 / NeuroRx by Fahn (2004)
  6. 10.1212/01.WNL.0000058760.13152.1A / Neurology by Ravina (2003)
  7. 10.1056/NEJM198911163212004 / N Engl J Med (1989)
  8. 10.1126/science.2502843 / Science by Tetrud (1989)
  9. 10.1212/WNL.51.2.520 / Neurology by Palhagen (1998)
  10. 10.1002/ana.410380512 / Ann Neurol by Olanow (1995)
  11. 10.1046/j.1468-1331.1999.650539.x / Eur J Neurol by Larsen (1999)
  12. 10.1002/ana.410400116 / Ann Neurol (1996)
  13. 10.1001/archneur.61.4.561 / Arch Neurol (2004)
  14. 10.1212/01.wnl.0000204007.46190.54 / Neurology by Palhagen (2006)
  15. 10.1056/NEJM199301213280305 / N Engl J Med (1993)
  16. 10.1001/archneur.59.10.1541 / Arch Neurol by Shults (2002)
  17. 10.1212/01.wnl.0000250355.28474.8e / Neurology (2007)
  18. 10.1212/01.wnl.0000238518.34389.12 / Neurology by Bender (2006)
  19. 10.1212/01.wnl.0000201252.57661.e1 / Neurology (2006)
  20. 10.1001/jama.287.13.1653 / JAMA (2002)
  21. 10.1002/ana.10609 / Ann Neurol by Whone (2003)
  22. 10.1056/NEJMoa033447 / N Engl J Med by Fahn (2004)
  23. 10.1016/S1353-8020(01)00040-2 / Parkinsonism Relat Disord by Jankovic (2002)
  24. 10.1212/WNL.60.1.69 / Neurology by Nutt (2003)
  25. 10.1002/ana.20737 / Ann Neurol by Lang (2006)
  26. 10.1016/j.neuroscience.2004.06.016 / Neuroscience by Poulter (2004)
  27. 10.1016/S1474-4422(06)70602-0 / Lancet Neurol by Olanow (2006)
  28. 10.1212/01.wnl.0000234884.42413.bc / Neurology by Shoulson (2006)
  29. 10.1212/WNL.66.10_suppl_4.S58 / Neurology by Hauser (2006)
  30. 10.1212/01.WNL.0000149403.14458.7F / Neurology by Ravina (2005)
  31. 10.1016/j.expneurol.2004.05.003 / Exp Neurol by Shults (2004)
  32. 10.1006/exnr.1999.7049 / Exp Neurol by Matthews (1999)
  33. 10.1097/00019052-199708000-00004 / Curr Opin Neurol by Stefanis (1997)
  34. 10.1038/35037739 / Nature by Yuan (2000)
  35. 10.1038/35040009 / Nat Rev Mol Cell Biol by Mattson (2000)
  36. 10.1038/nrn1100 / Nat Rev Neurosci by Vila (2003)
  37. 10.1212/WNL.66.10_suppl_4.S69 / Neurology by Olanow (2006)
  38. 10.1073/pnas.0511321103 / Proc Natl Acad Sci U S A by Hara (2006)
  39. 10.1016/S0969-9961(03)00125-6 / Neurobiol Dis by Andringa (2003)
  40. 10.1046/j.1460-9568.2000.00181.x / Eur J Neurosci by Andringa (2000)
  41. 10.1002/mds.20390 / Mov Disord by Silva (2005)
  42. 10.1517/13543784.14.11.1373 / Expert Opin Investig Drugs by Zhang (2005)
  43. 10.1016/j.bcp.2006.06.031 / Biochem Pharmacol by Waldmeier (2006)
  44. 10.1002/ana.410440719 / Ann Neurol by Burke (1998)
  45. 10.1523/JNEUROSCI.21-07-02247.2001 / J Neurosci by Hartmann (2001)
  46. 10.1212/WNL.66.10_suppl_4.S50 / Neurology by Kieburtz (2006)
  47. 10.1016/0014-2999(85)90168-2 / Eur J Pharmacol by Heikkila (1985)
  48. 10.1001/archneur.59.12.1937 / Arch Neurol (2002)
  49. {'key': 'R49-17-20070709', 'first-page': 'S570', 'volume': '21', 'author': 'Rascol', 'year': '2006', 'journal-title': 'Mov Disord'} / Mov Disord by Rascol (2006)
  50. 10.1002/ana.20361 / Ann Neurol by Elm (2005)
  51. 10.1212/01.wnl.0000201251.33253.fb / Neurology by Tilley (2006)
  52. 10.1212/01.wnl.0000204644.81956.65 / Neurology by Schwid (2006)
  53. 10.1073/pnas.251341998 / Proc Natl Acad Sci U S A by Du (2001)
  54. 10.1016/S1471-4892(01)00125-4 / Curr Opin Pharmacol by Gold (2002)
  55. 10.1523/JNEUROSCI.21-15-j0002.2001 / J Neurosci by Zhang (2001)
  56. 10.1038/35072550 / Nat Rev Neurosci by Beal (2001)
  57. 10.1002/bies.10067 / Bioessays by Betarbet (2002)
  58. 10.1073/pnas.0409713102 / Proc Natl Acad Sci U S A by Fornai (2005)
  59. 10.1111/j.1460-9568.2006.05192.x / Eur J Neurosci by Anderson (2006)
  60. 10.1602/neurorx.2.3.484 / NeuroRx by Bove (2005)
  61. 10.1002/ana.20186 / Ann Neurol by McNaught (2004)
  62. 10.1002/ana.20936 / Ann Neurol by McNaught (2006)
  63. 10.1002/ana.20939 / Ann Neurol by Beal (2006)
  64. 10.1002/ana.20932 / Ann Neurol by Zeng (2006)
  65. 10.1002/ana.20934 / Ann Neurol by Schapira (2006)
  66. 10.1002/ana.20937 / Ann Neurol by Bove (2006)
  67. 10.1002/ana.20938 / Ann Neurol by Manning-Bog (2006)
  68. 10.1002/ana.20935 / Ann Neurol by Kordower (2006)
Dates
Type When
Created 18 years, 1 month ago (July 9, 2007, 4:04 a.m.)
Deposited 4 years, 3 months ago (May 14, 2021, 4:05 a.m.)
Indexed 1 year, 2 months ago (June 5, 2024, 12:32 a.m.)
Issued 18 years, 1 month ago (Aug. 1, 2007)
Published 18 years, 1 month ago (Aug. 1, 2007)
Published Print 18 years, 1 month ago (Aug. 1, 2007)
Funders 0

None

@article{Hung_2007, title={Clinical trials for neuroprotection in Parkinson??s disease: overcoming angst and futility?}, volume={20}, ISSN={1350-7540}, url={http://dx.doi.org/10.1097/wco.0b013e32826388d6}, DOI={10.1097/wco.0b013e32826388d6}, number={4}, journal={Current Opinion in Neurology}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Hung, Albert Y and Schwarzschild, Michael A}, year={2007}, month=aug, pages={477–483} }